Plasma Betatrophin Levels and Carotid Atherosclerosis

Abstract EN

Aims.

Betatrophin is a recently identified circulating adipokine that may affect lipid and glucose metabolism.

However, the association between plasma betatrophin levels and carotid atherosclerosis has not been elucidated.

Methods.

We investigated plasma betatrophin levels in 153 subjects undergoing carotid ultrasonography.

The severity of plaque was evaluated as plaque score.

Results.

Of the 153 subjects, plaque was found in 63 (41%).

Plasma betatrophin levels were higher in 63 subjects with plaque than in 90 without plaque (median 906 vs.

729 pg/mL, P<0.025).

A stepwise increase in betatrophin levels was found depending on the plaque score: 729 pg/mL in score=0 (n=90), 802 pg/mL in score=1 (n=31), and 978 pg/mL in score≥2 (n=32) (P<0.01).

In particular, betatrophin levels in subjects with score≥2 were higher than in those with score=0 (P<0.05).

Moreover, betatrophin levels correlated with plaque score (r=0.23, P<0.01), but no significant correlation was found between betatrophin levels and triglyceride or HbA1c levels.

The percentage of subjects with betatrophin>800 pg/mL was higher in subjects with plaque than in those without plaque (65% vs.

44%) and was highest in score≥2 (78%) (P<0.005).

In the multivariate analysis, betatrophin level was not a significant factor for the presence of plaque but was a significant factor for plaque score≥2, independent of atherosclerotic risk factors.

The odds ratio for score≥2 was 4.9 (95% CI=1.9-12.8) for betatrophin>800 pg/mL.

Conclusions.

Plasma betatrophin levels were found to be high in subjects with carotid plaque and to be associated with the severity of plaque.

Betatrophin may play a role in the progression of carotid atherosclerosis.